(HLNE) Hamilton Lane - Ratings and Ratios
Private Equity, Venture Capital, Fund Of Funds, Direct Credit, Real Assets
HLNE EPS (Earnings per Share)
HLNE Revenue
Description: HLNE Hamilton Lane November 04, 2025
Hamilton Lane Incorporated (NASDAQ:HLNE) is a U.S.–based private-equity and venture-capital manager that originated in 1991 in Conshohocken, Pennsylvania and now operates a global network of offices across Europe, North America, Asia-Pacific, and the Middle East.
The firm runs a broad suite of alternative-investment strategies-including direct credit, fund-of-funds, evergreen vehicles, and real-asset platforms-targeting primary and secondary commitments across private-equity buyouts, special situations, growth equity, mezzanine, and venture-capital funds.
Its investment mandate emphasizes disruptive technologies and innovative business models, with a stated preference for sectors such as alternative energy, water purification, health-care technology, internet software, and other tech-enabled services. Deal sizes typically range from $0.25 million to $100 million, and Hamilton Lane often seeks majority-control positions in companies with small- to mid-size enterprise values.
Geographically, the firm pursues opportunities across a wide footprint that includes the United States (notably California, New York, and Sun Belt states), Europe, Asia-Pacific (including China, India, Korea, and Japan), the Middle East, Africa, and Latin America.
Key performance indicators (as of FY 2023) show $84 billion in assets under management (AUM), a 12% year-over-year increase in fee-related earnings, and a net income margin of roughly 18%. The private-equity market’s fundraising pace-estimated at $1.2 trillion in 2023-provides a robust pipeline of capital, while elevated interest rates are pressuring leveraged-buyout multiples and encouraging a shift toward lower-leverage, credit-focused strategies.
For readers looking to deepen their quantitative analysis, ValueRay offers a granular, data-driven dashboard that can help you benchmark Hamilton Lane’s valuation metrics against peers and track the impact of macro-economic shifts on its portfolio performance.
HLNE Stock Overview
| Market Cap in USD | 6,443m |
| Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception | 2017-03-01 |
HLNE Stock Ratings
| Growth Rating | 24.0% |
| Fundamental | 86.5% |
| Dividend Rating | 67.1% |
| Return 12m vs S&P 500 | -38.5% |
| Analyst Rating | 2.83 of 5 |
HLNE Dividends
| Dividend Yield 12m | 1.57% |
| Yield on Cost 5y | 3.15% |
| Annual Growth 5y | 12.07% |
| Payout Consistency | 100.0% |
| Payout Ratio | 54.6% |
HLNE Growth Ratios
| Growth Correlation 3m | -89.9% |
| Growth Correlation 12m | -54.7% |
| Growth Correlation 5y | 71.6% |
| CAGR 5y | 22.17% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.52 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.97 |
| Sharpe Ratio 12m | -0.43 |
| Alpha | -46.94 |
| Beta | 1.214 |
| Volatility | 37.54% |
| Current Volume | 733.1k |
| Average Volume 20d | 519k |
| Stop Loss | 125.8 (-4%) |
| Signal | 0.84 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (212.2m TTM) > 0 and > 6% of Revenue (6% = 41.5m TTM) |
| FCFTA 0.19 (>2.0%) and ΔFCFTA 9.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 27.81% (prev 14.03%; Δ 13.78pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 356.2m > Net Income 212.2m (YES >=105%, WARN >=100%) |
| Net Debt (49.6m) to EBITDA (315.6m) ratio: 0.16 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.60 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (54.5m) change vs 12m ago 0.78% (target <= -2.0% for YES) |
| Gross Margin 61.43% (prev 68.25%; Δ -6.82pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 43.62% (prev 45.60%; Δ -1.98pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 21.50 (EBITDA TTM 315.6m / Interest Expense TTM 14.2m) >= 6 (WARN >= 3) |
Altman Z'' 3.51
| (A) 0.11 = (Total Current Assets 510.9m - Total Current Liabilities 318.4m) / Total Assets 1.80b |
| (B) 0.27 = Retained Earnings (Balance) 486.9m / Total Assets 1.80b |
| (C) 0.19 = EBIT TTM 306.1m / Avg Total Assets 1.59b |
| (D) 0.60 = Book Value of Equity 487.1m / Total Liabilities 807.0m |
| Total Rating: 3.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.45
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 5.30% = 2.65 |
| 3. FCF Margin 49.73% = 7.50 |
| 4. Debt/Equity 0.48 = 2.39 |
| 5. Debt/Ebitda 0.16 = 2.48 |
| 6. ROIC - WACC (= 16.06)% = 12.50 |
| 7. RoE 31.07% = 2.50 |
| 8. Rev. Trend 70.23% = 5.27 |
| 9. EPS Trend 3.30% = 0.17 |
What is the price of HLNE shares?
Over the past week, the price has changed by +14.99%, over one month by +6.88%, over three months by -14.15% and over the past year by -29.85%.
Is Hamilton Lane a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HLNE is around 120.07 USD . This means that HLNE is currently overvalued and has a potential downside of -8.37%.
Is HLNE a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the HLNE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 157.2 | 19.9% |
| Analysts Target Price | 157.2 | 19.9% |
| ValueRay Target Price | 135.6 | 3.5% |
HLNE Fundamental Data Overview November 05, 2025
P/E Trailing = 22.0172
P/E Forward = 28.3286
P/S = 9.3077
P/B = 7.318
P/EG = 1.39
Beta = 1.214
Revenue TTM = 692.2m USD
EBIT TTM = 306.1m USD
EBITDA TTM = 315.6m USD
Long Term Debt = 288.6m USD (from longTermDebt, last quarter)
Short Term Debt = 21.7m USD (from shortTermDebt, last fiscal year)
Debt = 365.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 49.6m USD (from netDebt column, last quarter)
Enterprise Value = 6.49b USD (6.44b + Debt 365.5m - CCE 315.9m)
Interest Coverage Ratio = 21.50 (Ebit TTM 306.1m / Interest Expense TTM 14.2m)
FCF Yield = 5.30% (FCF TTM 344.2m / Enterprise Value 6.49b)
FCF Margin = 49.73% (FCF TTM 344.2m / Revenue TTM 692.2m)
Net Margin = 30.66% (Net Income TTM 212.2m / Revenue TTM 692.2m)
Gross Margin = 61.43% ((Revenue TTM 692.2m - Cost of Revenue TTM 267.0m) / Revenue TTM)
Gross Margin QoQ = 69.59% (prev 33.83%)
Tobins Q-Ratio = 3.60 (Enterprise Value 6.49b / Total Assets 1.80b)
Interest Expense / Debt = 1.06% (Interest Expense 3.86m / Debt 365.5m)
Taxrate = 19.26% (18.4m / 95.4m)
NOPAT = 247.2m (EBIT 306.1m * (1 - 19.26%))
Current Ratio = 1.60 (Total Current Assets 510.9m / Total Current Liabilities 318.4m)
Debt / Equity = 0.48 (Debt 365.5m / totalStockholderEquity, last quarter 758.8m)
Debt / EBITDA = 0.16 (Net Debt 49.6m / EBITDA 315.6m)
Debt / FCF = 0.14 (Net Debt 49.6m / FCF TTM 344.2m)
Total Stockholder Equity = 683.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.78% (Net Income 212.2m / Total Assets 1.80b)
RoE = 31.07% (Net Income TTM 212.2m / Total Stockholder Equity 683.0m)
RoCE = 31.51% (EBIT 306.1m / Capital Employed (Equity 683.0m + L.T.Debt 288.6m))
RoIC = 26.03% (NOPAT 247.2m / Invested Capital 949.4m)
WACC = 9.97% (E(6.44b)/V(6.81b) * Re(10.49%) + D(365.5m)/V(6.81b) * Rd(1.06%) * (1-Tc(0.19)))
Discount Rate = 10.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.45%
[DCF Debug] Terminal Value 73.38% ; FCFE base≈259.9m ; Y1≈311.4m ; Y5≈496.4m
Fair Price DCF = 128.7 (DCF Value 5.65b / Shares Outstanding 43.9m; 5y FCF grow 21.12% → 3.0% )
EPS Correlation: 3.30 | EPS CAGR: -45.23% | SUE: -4.0 | # QB: 0
Revenue Correlation: 70.23 | Revenue CAGR: 5.12% | SUE: 0.70 | # QB: 0
Additional Sources for HLNE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle